Form 4: Anterix Executive Reports Stock Withholding Transaction
Statement of Changes in Beneficial Ownership
Anterix Inc. Chief Regulatory and Communications Officer Christopher Guttman-McCabe reported the withholding of 1,426 shares to satisfy tax obligations.
Summary
- Christopher Guttman-McCabe, Chief Regulatory and Communications Officer at Anterix Inc., executed a transaction involving the withholding of 1,426 shares of common stock.
- The transaction occurred on May 18, 2026, at a price of $57.06 per share.
- The shares were withheld by the issuer to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following this transaction, the reporting person maintains a direct beneficial ownership of 41,466 shares of Anterix common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard administrative tax-withholding transaction rather than a strategic or market-driven move.
Positives
- The transaction is a routine administrative action related to tax obligations upon the vesting of equity compensation, rather than a discretionary open-market sale.
Negatives
- None identified; this is a standard tax-withholding event.
Risks
- None identified; this is a standard tax-withholding event.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that this filing is a routine disclosure of executive equity compensation management, common among publicly traded companies, and does not signal a change in corporate strategy or executive sentiment.
Comparison to Industry Standards
- The transaction follows standard corporate governance practices for handling tax liabilities associated with restricted stock unit (RSU) vesting.
Stakeholder Impact
- No material impact on shareholders, employees, or creditors as this is a routine equity settlement.
Key Dates
| Date | Description |
|---|---|
| 05/18/2026 | Date of the reported stock withholding transaction. |
| 05/20/2026 | Date the Form 4 was signed and filed. |
Keywords
Anterix, ATEX, Form 4, Insider Transaction, Equity Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.